Vivo Bio Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. To consider and approve the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech Ltd has informed BSE that its Board of Directors meeting is scheduled for May 29, 2026. The meeting will consider and approve two items: (1) the Audited Standalone and Consolidated Financial Results for Q4 and the year ended March 31, 2026, and (2) the amalgamation of Shri Shri Resorts Private Limited (Transferor Company) into Vivo Bio Tech Limited (Transferee Company). The amalgamation will be pursued under Sections 230 to 232 of the Companies Act, 2013 and SEBI Listing Regulations. The trading window for insiders will remain closed until May 31, 2026.
The proposed amalgamation of Shri Shri Resorts Private Limited into Vivo Bio Tech Limited could signal corporate restructuring activity. If approved, this may lead to future share transfers or dilution affecting existing shareholders. Regular Q4 results approval is standard procedure.